Indapta Therapeutics lands $22.5 million for cancer-fighting clinical trials
Like some other Houston-area clinical-stage companies that recently received venture backing, Indapta expects results in early 2025.
Building "Bridges" Across the Bayou City!
Like some other Houston-area clinical-stage companies that recently received venture backing, Indapta expects results in early 2025.